The first Teladoc Health trade was made in Q1 2017.
Since then Baillie Gifford bought shares nineteen more times and sold shares on nine occasions. The investor completely sold their stake between Q2 2023 and Q1 2024.
Avg closing price
Price range
Sold -1.59 Million shares
Q1 2024
Avg closing price
$18.15
Price range
$14.39
-
$22.03
Sold 9.7% shares (-170 Thousand shares)
Q4 2023
Avg closing price
$18.45
Price range
$15.57
-
$22.10
Sold 0.9% shares (-16.7 Thousand shares)
Q3 2023
Avg closing price
$23.34
Price range
$18.53
-
$29.77
Sold 63.2% shares (-3.05 Million shares)
Q2 2023
Avg closing price
$25.17
Price range
$22.42
-
$28.17
Increased shares by 1.7% (+79.7 Thousand shares)
Q1 2023
Avg closing price
$26.76
Price range
$22.29
-
$33.20
Sold 9.5% shares (-498 Thousand shares)
Q4 2022
Avg closing price
$26.96
Price range
$22.83
-
$33.31
Sold 32.2% shares (-2.49 Million shares)
Q3 2022
Avg closing price
$35.08
Price range
$25.35
-
$43.66
Sold 27.9% shares (-2.99 Million shares)
Q2 2022
Avg closing price
$42.47
Price range
$28.63
-
$75.86
Sold 1.4% shares (-149 Thousand shares)
Q1 2022
Avg closing price
$72.04
Price range
$50.79
-
$95.08
Increased shares by 23.5% (+2.07 Million shares)
Q4 2021
Avg closing price
$119.52
Price range
$87.43
-
$154.29
Increased shares by 4.6% (+388 Thousand shares)
Q3 2021
Avg closing price
$145.59
Price range
$125.92
-
$164.64
Increased shares by 6.0% (+478 Thousand shares)
Q2 2021
Avg closing price
$162.03
Price range
$132.71
-
$192.38
Increased shares by 9.7% (+700 Thousand shares)
Q1 2021
Avg closing price
$231.95
Price range
$171.30
-
$294.54
Increased shares by 16.0% (+997 Thousand shares)
Q4 2020
Avg closing price
$203.34
Price range
$172.44
-
$231.80
Increased shares by 4.6% (+276 Thousand shares)
Q3 2020
Avg closing price
$211.77
Price range
$183.75
-
$249.42
Increased shares by 3.3% (+192 Thousand shares)
Q2 2020
Avg closing price
$175.25
Price range
$139.10
-
$204.94
Increased shares by 0.7% (+41.8 Thousand shares)
Q1 2020
Avg closing price
$116.34
Price range
$82.96
-
$167.44
Increased shares by 52.6% (+1.97 Million shares)
Q4 2019
Avg closing price
$76.10
Price range
$61.54
-
$85.88
Increased shares by 325.3% (+2.87 Million shares)
Q3 2019